These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation. Barr ML; Sanchez JA; Seche LA; Schulman LL; Smith CR; Rose EA Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
15. OKT3 treatment of cardiac allograft rejection. Haverty TP; Sanders M; Sheahan M J Heart Lung Transplant; 1993; 12(4):591-8. PubMed ID: 8369321 [TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339 [TBL] [Abstract][Full Text] [Related]
17. Is it possible to reduce the number of endomyocardial biopsies with new immunosuppressive drugs? Lage E; Ballesteros S; Mogollón MV; Ordóñez A; Gómez S; Hernández A; Hinojosa R Transplant Proc; 2006 Oct; 38(8):2544-6. PubMed ID: 17097996 [TBL] [Abstract][Full Text] [Related]
18. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy. Cantarovich M; Latter DA; Loertscher R Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721 [TBL] [Abstract][Full Text] [Related]